Meanwhile, related companies such as Beckman Coulter rose 1.6%, while Abbott Laboratories slipped 0.1%, Bio-Rad Laboratories 2.4% and Meridian Bioscience 5.1%.

FORBES: Magazine Article

For molecular diagnostic tests Beckman Coulter has developed a nucleic-acid- sample detection instrument that separates fluorescent-dye-labeled DNA fragments for pattern recognition or further identification.

FORBES: Investment Guide

Beckman Coulter is an equipment supplier to this thriving industry.

FORBES: Magazine Article

Finally, Beckman Coulter (nyse: BEC - news - people ) is a cheap, defensive way to take advantage of biotechnology's future at 90% of revenue and 6 times cash flow.

FORBES: Next Year Will Be Better

Inverness, best known for its home pregnancy and fertility tests, beat out Beckman Coulter (nyse: BEC - news - people ), a Fullerton, Calif. medical test maker that launched a takeover attempt of Biosite in March.

FORBES